Byetta
Trovati 9 articoli
- Cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta
- Since October 2007, FDA ( Food and Drug Administration ) has received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta ( Exenatide ). Byetta is a medicine given by subcutaneous injection to help treat adults with type 2 diabetes. Of the 6 cases of hem... (Leggi Articolo)
- Diabetes: promising advances in islet cell transplants
- Researchers at University of Illinois at Chicago ( UIC ) have modified the procedure for islet cell transplantation and achieved insulin independence in diabetes patients with fewer but better-functioning pancreatic islet cells. The study results are published in the American Journal of Transp... (Leggi Articolo)
- Byetta: sustained improvements in blood glucose control and progressive weight loss after two years
- A two-year study has shown that Exenatide ( Byetta ) injection sustained improvements in blood glucose control and reduced body weight in people with type 2 diabetes who previously did not achieve adequate control of their blood sugar on common oral medications. After two years of treatment, p... (Leggi Articolo)
- Exenatide improves blood glucose as effectively as Insulin Glargine
- Results from a study indicate that Exenatide injection ( Byetta ) improves blood glucose levels as effectively as Insulin Glargine ( Lantus ) for patients with type 2 diabetes failing to achieve acceptable blood gluocse control on both Metformin and a sulfonylurea, two common oral diabetes medica... (Leggi Articolo)
- Diabetes mellitus: once weekly Byetta LAR improves glucose control
- The study was designed to assess the safety, tolerability and pharmacokinetics of Exenatide ( Byetta ) LAR (long-acting release ) given once a week. After 15 weeks, both doses of Exenatide LAR were well tolerated and expected therapeutic blood levels of Exenatide were achieved. Dose-dependent... (Leggi Articolo)
- Diabetes mellitus type 2: Exenatide shows sustained improvements in glucose control and progressive weight reduction
- Results from a study indicating that Exenatide ( Byetta ) injection showed sustained improvements in blood glucose control and progressive weight reduction through a year and a half of therapy for people with type 2 diabetes failing to achieve acceptable blood glucose control on Metformin and/or ... (Leggi Articolo)
- FDA has approved Byetta in patients with type 2 diabetes
- FDA ( Food and Drug Administration ) has approved Exenatide ( Byetta ), also known as synthetic exendin-4, injection as adjunctive therapy to improve blood sugar control in patients with type 2 diabetes who have not achieved adequate control on Metformin and/or a sulfonylurea. Exenatide is the... (Leggi Articolo)
- Type 2 diabetes: Galvus improves function of pancreatic islets and glycemic control
- Research suggests that the investigational drug Vildagliptin ( Galvus ) improves the function of pancreatic islets in both animals and humans. Improved pancreatic islet function is a long-standing goal for the treatment of type 2 diabetes. Researchers also reported that Vildagliptin, a novel ... (Leggi Articolo)
- Byetta reduces HbA1c in patients poorly controlled on Metformin
- Exenatide ( Byetta ) reduced HbA1c with no weight gain and no increased incidence of hypoglycemia in patients with type 2 diabetes failing to achieve glycemic control with Metformin. Exenatide is the first in a new class of drugs for the treatment of type 2 diabetes called incretin mimetics, a... (Leggi Articolo)
